Evolving Adjuvant Treatments for HER2+ Early Breast Cancer - Episode 5
Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss the clinical benefits reported with neratinib for the treatment of patients with HER2-positive early breast cancer.
Related Content: